feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Cream Promises Female Arousal Boost

New Cream Promises Female Arousal Boost

21 Dec, 2025

•

Summary

  • A new prescription cream uses Viagra's active ingredient, sildenafil.
  • The cream targets physical sexual arousal for women.
  • It aims for local genital application, improving blood flow and sensation.
New Cream Promises Female Arousal Boost

A new prescription cream, Dare to Play, has been introduced in the United States, utilizing sildenafil, the same active ingredient found in Viagra. This topical treatment is specifically formulated to enhance physical sexual arousal in women by promoting increased blood flow to the genital tissues. The cream is designed for direct application, aiming to improve sensation, warmth, swelling, and lubrication, which are key physical responses associated with arousal.

Clinical trials conducted by Daré Bioscience indicated improvements in arousal, desire, and orgasm when compared to a placebo. Notably, the studies reported no significant adverse side effects. This innovative approach allows sildenafil to act locally, avoiding the systemic effects that a pill form might entail, which would necessitate higher doses for women.

Women in several US states can now pre-order this compounded prescription cream, with nationwide availability anticipated in early 2026. Daré Bioscience is pursuing full FDA approval and plans a larger Phase 3 clinical trial. This development aims to provide women with a scientifically backed treatment option, comparable to the impact Viagra had for men.

trending

Morocco beats Cameroon in AFCON

trending

McIntyre wins WWE Championship

trending

Alysa Liu's Lady Gaga skate

trending

Indiana Hoosiers advance to championship

trending

Thunder rally past Grizzlies

trending

NBA Standings shake up

trending

India real estate investments rise

trending

Wrexham beats Nottingham Forest

trending

Real Sociedad late win

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The new prescription cream is called Dare to Play.
The cream contains sildenafil, the same active ingredient found in Viagra.
The cream is applied topically to the genital area to increase blood flow, which can improve sensation and arousal responses.

Read more news on

Healthside-arrowUnited Stateside-arrow

You may also like

Fugitive Scammer Claims Free NHS Care After 16 Years

8 Jan • 7 reads

article image

Dangerous ED Drugs Found in 'Male Enhancement' Supplement

17 Dec, 2025 • 146 reads

article image

FDA Expands Libido Pill Access Post-Menopause

16 Dec, 2025 • 114 reads

article image

New Cream Promises Female Arousal in 10 Minutes

11 Dec, 2025 • 104 reads

article image

Fake Viagra Sold in Toronto Store, Health Canada Warns

6 Dec, 2025 • 124 reads